pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,970 catalysts · 5,347 phase readout · 2,277 8k filing · 343 pdufa · 254 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 17 catalysts2026-08-06: 11 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,277
  • pdufa343
  • earnings254
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07335666: Virtual Reality Outperforms Game Card Distraction in Reducing Distress During Pediatric Wound Care

Sponsor: Agri Ibrahim Cecen University. Phase: NA. Conditions: Pediatric Wounds, Procedural Pain, Procedure-Related Anxiety, Procedural Fear

full page →ctgov ↗
›RECRUITINGphase readoutNCT05403151: Controls and Healthy Vasculature Initiative

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Vascular And Immunologic Diseases, Healthy Volunteers

full page →ctgov ↗
›RECRUITINGphase readoutNCT06493851: The Effect of Hyperbaric Oxygen Therapy for Acceleration Recovery After Anterior Cruciate Ligament Reconstruction(ACLR)

Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Anterior Cruciate Ligament Reconstruction

full page →ctgov ↗
›TERMINATEDphase readoutNCT06779851: A Study to Evaluate Safety and Tolerability of BPT567 in Patients With Advanced Solid Tumors

Sponsor: Bright Peak Therapeutics Inc. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT05860751: The Effect of Dry Needling With Electrical Stimulation on Individuals With Restless Legs Syndrome

Sponsor: Mayo Clinic. Phase: NA. Conditions: Neck Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT05794451: Developing an Artificial Intelligence System to Detect Cognitive Impairment

Sponsor: University of Haifa. Phase: . Conditions: Alzheimer Disease, Healthy Aging, Mild Cognitive Impairment

full page →ctgov ↗
›COMPLETEDphase readoutNCT00337051: Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)

Sponsor: University Hospital, Bordeaux. Phase: PHASE3. Conditions: End-stage Chronic Renal Disease, Severe Acute Kidney Failure, Renal Transplantation

full page →ctgov ↗
›COMPLETEDphase readoutNCT03390751: Atropine Weight and Risk of Postoperative Confusion in the Elderly

Sponsor: University Hospital, Toulouse. Phase: . Conditions: Aging

full page →ctgov ↗
›RECRUITINGphase readoutNCT07225751: A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions.

Sponsor: Kuros Biosurgery AG. Phase: NA. Conditions: Ankle Arthrodesis or Arthroplasty, Hindfoot Fusion, Ankle Deformity, Ankle Disease, Hindfoot Arthrodesis, Hindfoot Pathologies

full page →ctgov ↗
›RECRUITINGphase readoutNCT06448351: Manipulating E-Cigarette Nicotine to Promote Public Health

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: NA. Conditions: Tobacco-Related Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT00659529: Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease

Sponsor: National Jewish Health. Phase: PHASE1. Conditions: Cystic Fibrosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT00473031: The Effect of Weight Loss and Dietary Protein Intake on Bone

Sponsor: Rutgers University. Phase: NA. Conditions: Weight Loss, Bone Density

full page →ctgov ↗
›RECRUITINGphase readoutNCT07421453: Implementation of an Enhanced Recovery Pathway for Burr-hole Drainage in Patients With a Chronic Subdural Hematoma

Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: . Conditions: Chronic Subdural Hematoma, Chronic Subdural Hematomas

full page →ctgov ↗
›COMPLETEDphase readoutNCT02476253: Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill

Sponsor: University Hospital, Montpellier. Phase: PHASE3. Conditions: Metabolic Acidosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT02086253: Role of Endothelin-1 in Flow-mediated Dilatation

Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Healthy Conditions

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06975553: Extubation Safety Via Microstream EtCO₂ (IPI) Monitoring

Sponsor: Chinese PLA General Hospital. Phase: NA. Conditions: Hypoxemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07630597: Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Lifestyle Intervention

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School. Phase: NA. Conditions: Obesity & Overweight

full page →ctgov ↗
›RECRUITINGphase readoutNCT06825897: Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe

Sponsor: Santiago Ortega Gutierrez. Phase: NA. Conditions: Stroke, Acute

full page →ctgov ↗
›AVAILABLEphase readoutNCT04159597: Expanded Access to Upadacitinib

Sponsor: AbbVie. Phase: . Conditions: Crohn Disease, Ulcerative Colitis, Idiopathic Arthritis (Including sJIA, pJIA, or JPsA), Atopic Dermatitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06658197: Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

Sponsor: Xuanwu Hospital, Beijing. Phase: PHASE3. Conditions: Stroke, Ischemic, Stroke, Acute, Thrombosis, Brain, Drug Effect

full page →ctgov ↗
›RECRUITINGphase readoutNCT07216560: First-in-human Study of 7MW4911 in GI Cancer

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.. Phase: PHASE1. Conditions: GI Cancers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07461220: Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

Sponsor: Integrative Research Laboratories AB. Phase: PHASE1. Conditions: PARKINSON DISEASE (Disorder), Apathy, Safety

full page →ctgov ↗
›RECRUITINGphase readoutNCT05600920: A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Idiopathic CD4 Lymphopenia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05634720: Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

Sponsor: Duke University. Phase: PHASE4. Conditions: Pancreatic Ductal Adenocarcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05571982: Comparison of the Efficacy of Tidal Volume Breathing and Vital Capacity Breathing During High-flow Nasal Oxygen

Sponsor: Yonsei University. Phase: NA. Conditions: Adult Patients 20 Years of Age or Older Who Are Planning to Undergo Surgery Under General Anesthesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06384924: Raman Spectroscopy and Skin Cancer

Sponsor: Tiezhi Zhang. Phase: . Conditions: Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07622459: Circadian Feeding and Reciprocal Scent Intervention in NICU

Sponsor: Inonu University. Phase: NA. Conditions: Prematurity, Mechanical Ventilation

full page →ctgov ↗
›COMPLETEDphase readoutNCT03325959: Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome

Sponsor: Assaf-Harofeh Medical Center. Phase: NA. Conditions: Fibromyalgia, Hyperbaric Oxygen

full page →ctgov ↗
›RECRUITINGphase readoutNCT07469059: Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and/or Proteinuria Using Ultrasound Localization Microscopy

Sponsor: University of Erlangen-Nürnberg Medical School. Phase: . Conditions: Nephritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06587880: The Effect of Different Types of Mouthwash on Extraction Sockets' Healing

Sponsor: University of Jordan. Phase: PHASE4. Conditions: Extraction Socket Healing, Quality of Life, Postoperative Complications

full page →ctgov ↗
›RECRUITINGphase readoutNCT03869996: Total Knee Arthroplasty: Fast Track Protocol is the Future?

Sponsor: Istituto Ortopedico Rizzoli. Phase: NA. Conditions: Osteoarthritis, Knee, Arthropathy of Knee

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07604727: AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation

Sponsor: University Medical Center Groningen. Phase: NA. Conditions: Atrial Fibrillation (AF), Heart Failure, Cardiac Pacing

full page →ctgov ↗
›COMPLETEDphase readoutNCT04716127: A Proximity-incentive Strategy for Cervical Cancer Screening

Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Cervical Cancer, Uterine Cervical Disease, Human Papilloma Virus

full page →ctgov ↗
›COMPLETEDphase readoutNCT05508061: Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

Sponsor: Inreda Diabetic B.V.. Phase: NA. Conditions: Type 1 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT02629042: Efficacy of Oral Prednisolone on Pain Reduction in Emergency Care of Acute Irreversible Pulpitis

Sponsor: University Hospital, Bordeaux. Phase: PHASE3. Conditions: Pulpitis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07624786: Patient-Ventilator Asynchrony: Occurence and Clinical Impact in Usual Care

Sponsor: Erasmus Medical Center. Phase: . Conditions: Mechanical Ventilation, Patient-Ventilator Asynchrony

full page →ctgov ↗
›RECRUITINGphase readoutNCT06679270: Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

Sponsor: Amryt Pharma. Phase: PHASE3. Conditions: Familial Partial Lipodystrophy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07214870: A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Fatty Liver Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07560969: Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African Americans

Sponsor: University of Missouri, Kansas City. Phase: NA. Conditions: Diabetes, Physical Activity, Food Security, Nutrition Security

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07270783: Healthy Volunteer Study

Sponsor: InventisBio Co., Ltd. Phase: PHASE1. Conditions: Healthy Volunteer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06456983: Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial

Sponsor: Central Institute of Mental Health, Mannheim. Phase: NA. Conditions: Schizophrenia, Treatment Resistant Schizophrenia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04602741: Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Schizophrenia, Schizo Affective Disorder, Psychotic Disorders

full page →ctgov ↗
›SUSPENDEDphase readoutNCT03588754: Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?

Sponsor: Yale University. Phase: PHASE2. Conditions: Alcohol Drinking

full page →ctgov ↗
›RECRUITINGphase readoutNCT06144554: Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes

Sponsor: Insulet Corporation. Phase: . Conditions: Type 1 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT01581554: Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Chronic Hepatitis B e Antigen Positive, Chronic Hepatitis B e Antigen Negative

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05012254: Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

Sponsor: Fundación GECP. Phase: PHASE2. Conditions: Non Small Cell Lung Cancer, Brain Metastases, Adult, Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07064005: Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

Sponsor: Pravat Mandal. Phase: PHASE1. Conditions: Parkinsons Disease (PD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07538505: Testing a Diabetes Care Program in Rural and Low-Income Clinics

Sponsor: The University of Texas Medical Branch, Galveston. Phase: NA. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT00340405: Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Lung Cancer

full page →ctgov ↗
›SUSPENDEDphase readoutNCT05924594: Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

Sponsor: Cingulate Therapeutics. Phase: PHASE3. Conditions: ADHD, ADHD - Combined Type, Attention Deficit Hyper Activity, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder With Hyperactivity, Attention Deficit Hyperactivity Disorder Combined, Attention-deficit Hyperactivity

full page →ctgov ↗
← prev
page 113 of 160
next →